|
[1]
|
石礼平, 张国壮, 刘丛盛, 等. 三七化学成分和药理作用研究概况及质量标志物的预测[J]. 中国中药杂志, 2023, 48(8): 2059-2067.
|
|
[2]
|
任恺, 段维勋, 俞波, 等. 中药皂苷成分对高血压大鼠主动脉血管内皮功能相关因子的影响[J]. 西北大学学报(自然科学版), 2018, 48(6): 783-786.
|
|
[3]
|
Wang, B., Gao, X., Zhang, Y., Xiao, Y., Chen, T., Shi, Z., et al. (2025) The Role of Panax Notoginseng Saponins in Cerebrovascular Neurological Disorders: An Overview of Mechanisms and Functions. Frontiers in Pharmacology, 16, Article 1693253. [Google Scholar] [CrossRef]
|
|
[4]
|
高家乐. 三七总皂苷对缺血性中风后急性期神经保护和恢复期修复的机制研究[D]: [博士学位论文]. 北京: 中国中医科学院, 2024.
|
|
[5]
|
Zeng, X., Zhao, J., Nie, Y., Mo, J., Zhou, T. and Jiang, J. (2026) Panax Notoginseng Saponins against Ischemic Stroke: From Molecule to Clinic. Journal of Ethnopharmacology, 356, Article 120834. [Google Scholar] [CrossRef]
|
|
[6]
|
Lv, N., Wang, L., Zeng, M., Wang, Y., Yu, B., Zeng, W., et al. (2024) Saponins as Therapeutic Candidates for Atherosclerosis. Phytotherapy Research, 38, 1651-1680. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zhang, X., Zhang, B., Zhang, C., Sun, G. and Sun, X. (2021) Effect of Panax Notoginseng Saponins and Major Anti-Obesity Components on Weight Loss. Frontiers in Pharmacology, 11, Article 601751. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
常猛, 陈漪漪, 范亚红, 等. 三七皂苷R1通过激活SLC7A11/GPX4通路抑制铁死亡改善小鼠心肌缺血再灌注损伤后心脏重塑[J]. 中草药, 2026, 57(1): 175-184.
|
|
[9]
|
王汉隆, 孙洋, 刘莎莎, 等. 三七皂苷R1药理作用机制与神经保护作用研究进展[J]. 中国药理学通报, 2024, 40(11): 2020-2025.
|
|
[10]
|
Li, M., Huang, Z., Zhang, R. and Zhou, J. (2024) Review of Probiotics, Gut Microorganisms, and Their Enzymes Involved in the Conversion of Ginsenosides. Food Bioscience, 58, Article 103829. [Google Scholar] [CrossRef]
|
|
[11]
|
Zhang, H., Li, J., Diao, M., Li, J. and Xie, N. (2024) Production and Pharmaceutical Research of Minor Saponins in Panax Notoginseng (Sanqi): Current Status and Future Prospects. Phytochemistry, 223, Article 114099. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Navarro del Hierro, J., Herrera, T., Fornari, T., Reglero, G. and Martin, D. (2018) The Gastrointestinal Behavior of Saponins and Its Significance for Their Bioavailability and Bioactivities. Journal of Functional Foods, 40, 484-497. [Google Scholar] [CrossRef]
|
|
[13]
|
王新红, 张迟, 刘琳, 等. 皂苷类成分与肠道菌群相互作用研究进展[J]. 中成药, 2021, 43(7): 1834-1839.
|
|
[14]
|
韩冰, 李静娜, 吕西雨, 等. 肠道菌群代谢转化中药皂苷类成分研究进展[J]. 中草药, 2023, 54(20): 6922-6932.
|
|
[15]
|
袁松竹, 王斌, 周旋, 等. 稀有人参皂苷生物转化的研究进展[J]. 食品工业科技, 2023, 44(12): 480-489.
|
|
[16]
|
Wei, W., Li, M., Pan, L., Shao, M., He, X., Li, Y., et al. (2025) Inter-Species and Individualized Biotransformation of Five Saponins by Human Being-and Mouse-Derived Fecal Microbiota. Chinese Medicine, 20, Article No. 132. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kim, K.A., Jung, I.H., Park, S.H., et al. (2013) Comparative Analysis of the Gut Microbiota in People with Different Levels of Ginsenoside Rb1 Degradation to Compound K. PLOS ONE, 8, e62409. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Zhang, M., Wang, Y., Wu, Y., Li, F., Han, M., Dai, Y., et al. (2021) In Vitro Transformation of Protopanaxadiol Saponins in Human Intestinal Flora and Its Effect on Intestinal Flora. Evidence-Based Complementary and Alternative Medicine, 2021, 1-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Zhuang, T., Li, W., Yang, L., Wang, Z., Ding, L. and Zhou, M. (2021) Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications. Frontiers in Pharmacology, 12, Article 731288. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Chen, L., Tai, W.C.S. and Hsiao, W.L.W. (2015) Dietary Saponins from Four Popular Herbal Tea Exert Prebiotic-Like Effects on Gut Microbiota in C57BL/6 Mice. Journal of Functional Foods, 17, 892-902. [Google Scholar] [CrossRef]
|
|
[21]
|
路婧, 夏雪娟, 黄骏楠, 等. 不同富营养培养基对人肠道菌群的体外培养效果比较分析[J]. 食品与发酵工业, 2024, 50(24): 201-211.
|
|
[22]
|
Fu, Y.S., Chen, K.N., Zhang, J.N., et al. (2019) Evaluation of the Effects of Four Media on Human Intestinal Microbiota Culture in Vitro. AMB Express, 9, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Goodman, A.L., Kallstrom, G., Faith, J.J., Reyes, A., Moore, A., Dantas, G., et al. (2011) Extensive Personal Human Gut Microbiota Culture Collections Characterized and Manipulated in Gnotobiotic Mice. Proceedings of the National Academy of Sciences, 108, 6252-6257. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Qu, Z.P., Liu, H.B., Yang, J., et al. (2025) Selective Utilization of Medicinal Polysaccharides by Human Gut Bacteroides and Parabacteroides Species. Nature Communications, 16, Article No. 638. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Dong, W.W., Xuan, F.L., Zhong, F.L., et al. (2017) Comparative Analysis of the Rats’ Gut Microbiota Composition in Animals with Different Ginsenosides Metabolizing Activity. Journal of Agricultural and Food Chemistry, 65, 327-337. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Wang, L., Chen, M., Shao, L., Zhang, W., Li, X. and Huang, W. (2021) Personalized Bioconversion of Panax notoginseng Saponins Mediated by Gut Microbiota between Two Different Diet-Pattern Healthy Subjects. Chinese Medicine, 16, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Bakkeren, E., Piskovsky, V. and Foster, K.R. (2025) Metabolic Ecology of Microbiomes: Nutrient Competition, Host Benefits, and Community Engineering. Cell Host & Microbe, 33, 790-807. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Shi, H., Newton, D.P., Nguyen, T.H., Estrela, S., Sanchez, J., Tu, M., et al. (2025) Nutrient Competition Predicts Gut Microbiome Restructuring under Drug Perturbations. Cell, 188, 6971-6986.e14. [Google Scholar] [CrossRef]
|
|
[29]
|
Ma, J., Piao, X., Mahfuz, S., Long, S. and Wang, J. (2022) The Interaction among Gut Microbes, the Intestinal Barrier and Short Chain Fatty Acids. Animal Nutrition, 9, 159-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Mukhopadhya, I., Martin, J.C., Shaw, S., Gutierrez-Torrejon, M., Boteva, N., McKinley, A.J., et al. (2025) Novel Insights into Carbohydrate Utilisation, Antimicrobial Resistance, and Sporulation Potential in Roseburia Intestinalis Isolates across Diverse Geographical Locations. Gut Microbes, 17, Article 2473516. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Bocchio, F., Mancabelli, L., Milani, C., Lugli, G.A., Tarracchini, C., Longhi, G., et al. (2025) Compendium of Bifidobacterium-Based Probiotics: Characteristics and Therapeutic Impact on Human Diseases. Microbiome Research Reports, 4, Article 2. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Yang, J., Ren, H., Cao, J., Fu, J., Wang, J., Su, Z., et al. (2025) Gut Commensal Lachnospiraceae Bacteria Contribute to Anti-Colitis Effects of Lactiplantibacillus Plantarum Exopolysaccharides. International Journal of Biological Macromolecules, 309, Article 142815. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Wu, J., Zhao, Y., Wang, X., Kong, L., Johnston, L.J., Lu, L., et al. (2022) Dietary Nutrients Shape Gut Microbes and Intestinal Mucosa via Epigenetic Modifications. Critical Reviews in Food Science and Nutrition, 62, 783-797. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Zheng, F., Zhang, M.Y., Wu, Y.X., et al. (2021) Biotransformation of Ginsenosides (Rb1, Rb2, Rb3, Rc) in Human Intestinal Bacteria and Its Effect on Intestinal Flora. Chemistry & Biodiversity, 18, e2100296.
|
|
[35]
|
Shi, M., Fan, H., Liu, H. and Zhang, Y. (2024) Effects of Saponins Rb1 and Re in American Ginseng Intervention on Intestinal Microbiota of Aging Model. Frontiers in Nutrition, 11, Article 1435778. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Chen, H., Shen, J., Li, H., Zheng, X., Kang, D., Xu, Y., et al. (2020) Ginsenoside Rb1 Exerts Neuroprotective Effects through Regulation of Lactobacillus Helveticus Abundance and GABAA Receptor Expression. Journal of Ginseng Research, 44, 86-95. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zhang, K.X., Zhu, Y., Song, S.X., et al. (2024) Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism. Molecules, 29, Article 1108. [Google Scholar] [CrossRef] [PubMed]
|